Sponsor Pipeline

Ratio Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07156565 Actinium Therapy for Late-stage Aggressive Sarcomas Advanced Soft Tissue Sarcoma Recruiting
Disease Areas
Sarcoma (1)
Get alerts when Ratio Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free